{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:52:32Z","timestamp":1791406352433,"version":"4.3.3"},"reference-count":48,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"10","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Precis Oncol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Modern cancer diagnostics is heavily reliant on molecular data. Next-generation sequencing using liquid biopsy (LB) is primarily focused on identifying predictive and prognostic biomarkers to guide systemic therapy decision making. However, additional findings including genomic variants of possible or probable germline origin are detected in a significant minority of patients (3%-18%), with significant implications for patients and their families. Pretest information provision regarding both the purpose and potential benefits of the test and additional findings on LB varies in clinical practice, with little guidance for clinicians regarding the degree of detail required regarding possible additional findings. LB requires explicit disclosure of these aspects. Implementing a standardized, context-dependent approach to this discussion, with nationally standardized information provision tools, should be prioritized to enable patient-centered decision making regarding LB, without prioritizing the incidentalome over the primary purpose of the test\u2014refining and optimizing treatment options.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/po-26-00366","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:59:12Z","timestamp":1791403152000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Genomic Analysis Using Liquid Biopsy: Considerations for Pretest Counseling in UK Practice"],"prefix":"10.1200","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5827-3464","authenticated-orcid":true,"given":"David John","family":"McMahon","sequence":"first","affiliation":[{"name":"Royal Marsden Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Bancroft","sequence":"additional","affiliation":[{"name":"Royal Marsden Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9360-8194","authenticated-orcid":true,"given":"George J.","family":"Burghel","sequence":"additional","affiliation":[{"name":"Division of Cancer Sciences, Faculty of Biology, Medicine and Health, School of Medical Sciences, The University of Manchester, Manchester, United Kingdom"},{"name":"Manchester Cancer Genomic Medicine, North West Genomic Laboratory Hub, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8994-4056","authenticated-orcid":true,"given":"Ellen","family":"Copson","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"},{"name":"NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2901-0742","authenticated-orcid":true,"given":"Michael","family":"Hubank","sequence":"additional","affiliation":[{"name":"Royal Marsden Hospital, London, United Kingdom"},{"name":"The Institute of Cancer Research, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wiggins","sequence":"additional","affiliation":[{"name":"Royal Marsden Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1739-7986","authenticated-orcid":true,"given":"Katie","family":"Snape","sequence":"additional","affiliation":[{"name":"Clinical Genetics, 7(th) Floor Borough Wing, Guy's Hospital, London, United Kingdom"},{"name":"South West Thames Regional Genomics Service, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2606-1082","authenticated-orcid":true,"given":"Natalie","family":"Cook","sequence":"additional","affiliation":[{"name":"Division of Cancer Sciences, Faculty of Biology, Medicine and Health, School of Medical Sciences, The University of Manchester, Manchester, United Kingdom"},{"name":"The Christie NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Frayling","sequence":"additional","affiliation":[{"name":"Department of Pathology, St Vincent's University Hospital, Dublin 4, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4480-1147","authenticated-orcid":true,"given":"Matthew J.","family":"Murray","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, Centre for Personalised Medicine, University of Oxford, Oxford, United Kingdom"},{"name":"Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9168-0387","authenticated-orcid":true,"given":"Alastair","family":"Greystoke","sequence":"additional","affiliation":[{"name":"Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Newcastle Upon Tyne, United Kingdom"},{"name":"Newcastle University, Newcastle Upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7540-3064","authenticated-orcid":true,"given":"Matthew G.","family":"Krebs","sequence":"additional","affiliation":[{"name":"Division of Cancer Sciences, Faculty of Biology, Medicine and Health, School of Medical Sciences, The University of Manchester, Manchester, United Kingdom"},{"name":"The Christie NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2087-4963","authenticated-orcid":true,"given":"Sanjay","family":"Popat","sequence":"additional","affiliation":[{"name":"Royal Marsden Hospital, London, United Kingdom"},{"name":"The Institute of Cancer Research, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri Patricia","family":"McVeigh","sequence":"additional","affiliation":[{"name":"Royal Marsden Hospital, London, United Kingdom"},{"name":"The Institute of Cancer Research, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of UK Circulating Biomarkers Network of Excellence and the National ctDNA Steering Committee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ryves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Byron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Starczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayliss","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naureen","family":"Starling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Hargrave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Scarpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maricica","family":"Zabrautanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Chaplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratixa","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Pickard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markella","family":"Boudioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Sutcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikel Valganon","family":"Petrizan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Pickard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Starczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Sutcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Schlecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ryves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirupa","family":"Murugaesu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Morilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2017.01.003"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ibneur.2025.04.007"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02021-w"},{"key":"e_1_3_6_5_2","unstructured":"NHS England: NHS first in world to roll out \u2018revolutionary\u2019 blood test for cancer patients. https:\/\/www.england.nhs.uk\/2025\/05\/nhs-first-in-world-to-roll-out-revolutionary-blood-test-for-cancer-patients\/"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2022.01.009"},{"key":"e_1_3_6_7_2","article-title":"Association between availability of molecular genotyping results and overall survival in patients with advanced nonsquamous non\u2013small-cell lung cancer","author":"Aggarwal C","unstructured":"Aggarwal C, Marmarelis ME, Hwang WT, et al: Association between availability of molecular genotyping results and overall survival in patients with advanced nonsquamous non\u2013small-cell lung cancer. JCO Precis Oncol 10.1200\/PO.23.00191","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.q1706"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.5208"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0652-7"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1421839112"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aab4082"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409405"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-05-644690"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy263"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2016.10.002"},{"key":"e_1_3_6_17_2","volume-title":"Association for Clinical Genomic Science (ACGS) Guidelines for the Classification of Oncogenicity of Somatic Variants in Cancer-Recommendations by the UK Somatic Variant Interpretation Group (SVIG-UK)","author":"Burghel GJ","year":"2025","unstructured":"Burghel GJ, Mason J, Baker K, et al: Association for Clinical Genomic Science (ACGS) Guidelines for the Classification of Oncogenicity of Somatic Variants in Cancer-Recommendations by the UK Somatic Variant Interpretation Group (SVIG-UK). 2025"},{"key":"e_1_3_6_18_2","article-title":"Comparison of somatic and germline variant interpretation in hereditary cancer genes","author":"Moody EW","unstructured":"Moody EW, Vagher J, Espinel W, et al: Comparison of somatic and germline variant interpretation in hereditary cancer genes. JCO Precis Oncol 10.1200\/PO.19.00144","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac164"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2024-221738"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2021-108355"},{"key":"e_1_3_6_22_2","first-page":"e250048","article-title":"To screen or not to screen: Complexity of SDHA mutation management","volume":"6","author":"Mohamed E","year":"2026","unstructured":"Mohamed E, Eeles R, McVeigh T, et al: To screen or not to screen: Complexity of SDHA mutation management. Endocr Oncol (Bristol, England) 6:e250048, 2026","journal-title":"Endocr Oncol (Bristol, England)"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2025-110947"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/jgc4.1789"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.104543"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2023.05.028"},{"key":"e_1_3_6_27_2","volume-title":"Managing Incidental Fi Ndings Guidance for Rare and Inherited Disease Diagnostic Genomic Testing","author":"BSGM","year":"2024","unstructured":"BSGM: Managing Incidental Fi Ndings Guidance for Rare and Inherited Disease Diagnostic Genomic Testing. 2024. www.bsgm.org.uk"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00863-3"},{"key":"e_1_3_6_29_2","first-page":"100775","article-title":"The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours","volume":"36","author":"El Helali A","year":"2023","unstructured":"El Helali A, Lam TC, Ko EYL, et al: The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours. Lancet Reg Health West Pac 36:100775, 2023","journal-title":"Lancet Reg Health West Pac"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71287"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6758"},{"key":"e_1_3_6_32_2","first-page":"1","article-title":"What Do patients with cancer know, or want to know, about genomic tumor sequencing and genetic testing? A state-of-the-art review","volume":"15","author":"Stewart L","year":"2024","unstructured":"Stewart L, Ward LD: What Do patients with cancer know, or want to know, about genomic tumor sequencing and genetic testing? A state-of-the-art review. J Adv Pract Oncol 15:1-14, 2024","journal-title":"J Adv Pract Oncol"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.35328"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13930"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2021.05.018"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13928"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18675"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI190264"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-025-01945-3"},{"key":"e_1_3_6_40_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a036582"},{"key":"e_1_3_6_41_2","volume-title":"Montgomery (Appellant) v Lanarkshire Health Board (Respondent) (Scotland)\u2014UK Supreme Court","unstructured":"Montgomery (Appellant) v Lanarkshire Health Board (Respondent) (Scotland)\u2014UK Supreme Court. https:\/\/www.supremecourt.uk\/cases\/uksc-2013-0136"},{"key":"e_1_3_6_42_2","unstructured":"Factsheet: Key legislation and case law relating to decision making and consent. www.gmc-uk.org\/guidance"},{"key":"e_1_3_6_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70095"},{"key":"e_1_3_6_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02832-2"},{"key":"e_1_3_6_45_2","unstructured":"NHS England \u00bb NHS expands HIV opt-out testing to 30 more A&Es. https:\/\/www.england.nhs.uk\/2025\/02\/nhs-expands-hiv-opt-out-testing\/"},{"key":"e_1_3_6_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-020-0783-8"},{"key":"e_1_3_6_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-025-03252-6"},{"key":"e_1_3_6_48_2","volume-title":"Implementation Policy for the Reporting of Additional Genomic Targets for Solid Tumours to Aid Patient Access to Emerging Treatments and Clinical Trials","author":"Rachel Butler. GU-LAB-008","year":"2025","unstructured":"Rachel Butler. GU-LAB-008: Implementation Policy for the Reporting of Additional Genomic Targets for Solid Tumours to Aid Patient Access to Emerging Treatments and Clinical Trials. 2025"},{"key":"e_1_3_6_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.05.520"}],"container-title":["JCO Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/PO-26-00366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:59:32Z","timestamp":1791403172000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/PO-26-00366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1200\/PO-26-00366"],"URL":"https:\/\/doi.org\/10.1200\/po-26-00366","relation":{},"ISSN":["2473-4284"],"issn-type":[{"value":"2473-4284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"2026-03-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2600366"}}